Colorado Therapeutics Overview

  • Founded
  • 2015

  • Status
  • Private

  • Employees
  • 11

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $2.57M

Colorado Therapeutics General Information


Developer of tissue processing technology designed to produce strong, durable, and biocompatible tissue from xenogenic sources. The company's technology focuses on developing xenogenic biologic tissue matrix products and therapeutic devices for a broad range of soft tissue reinforcement, and regenerative and vascular applications, enabling medical professionals to effectively address unmet patient needs in soft tissue repair.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Primary Office
  • 486 South Pierce Avenue
  • Suite A
  • Louisville, CO 80027
  • United States
+1 (303) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Colorado Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 17-Apr-2017 $2.57M 00.000 Completed Generating Revenue
1. Seed Round 18-Apr-2016 00.00 00.00 Completed Generating Revenue
To view Colorado Therapeutics’s complete valuation and funding history, request access »

Colorado Therapeutics Executive Team (4)

Name Title Board Seat Contact Info
Joseph Horn Founder, Board Member, President & Chief Executive Officer
Eric Schauble Vice President, Corporate Development
Thomas Reagan Corporate and Financial Advisor & Board Member
You’re viewing 3 of 4 executive team members. Get the full list »

Colorado Therapeutics Board Members (2)

Name Representing Role Since
James Gleeson Colorado Therapeutics Board Member 000 0000
Thomas Reagan Colorado Therapeutics Corporate and Financial Advisor & Board Member 000 0000
To view Colorado Therapeutics’s complete board members history, request access »

Colorado Therapeutics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial